212 related articles for article (PubMed ID: 22380844)
1. Effect of estrogen sulfation by SULT1E1 and PAPSS on the development of estrogen-dependent cancers.
Xu Y; Liu X; Guo F; Ning Y; Zhi X; Wang X; Chen S; Yin L; Li X
Cancer Sci; 2012 Jun; 103(6):1000-9. PubMed ID: 22380844
[TBL] [Abstract][Full Text] [Related]
2. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase: radiochemical enzymatic assay, biochemical properties, and hepatic variation.
Xu Z; Wood TC; Adjei AA; Weinshilboum RM
Drug Metab Dispos; 2001 Feb; 29(2):172-8. PubMed ID: 11159808
[TBL] [Abstract][Full Text] [Related]
3. Enhanced PAPSS2/VCAN sulfation axis is essential for Snail-mediated breast cancer cell migration and metastasis.
Zhang Y; Zou X; Qian W; Weng X; Zhang L; Zhang L; Wang S; Cao X; Ma L; Wei G; Wu Y; Hou Z
Cell Death Differ; 2019 Mar; 26(3):565-579. PubMed ID: 29955124
[TBL] [Abstract][Full Text] [Related]
4. Human 3'-phosphoadenosine 5'-phosphosulfate (PAPS) synthase: biochemistry, molecular biology and genetic deficiency.
Venkatachalam KV
IUBMB Life; 2003 Jan; 55(1):1-11. PubMed ID: 12716056
[TBL] [Abstract][Full Text] [Related]
5. Glucocorticoids antagonize estrogens by glucocorticoid receptor-mediated activation of estrogen sulfotransferase.
Gong H; Jarzynka MJ; Cole TJ; Lee JH; Wada T; Zhang B; Gao J; Song WC; DeFranco DB; Cheng SY; Xie W
Cancer Res; 2008 Sep; 68(18):7386-93. PubMed ID: 18794126
[TBL] [Abstract][Full Text] [Related]
6. Human DHEA sulfation requires direct interaction between PAPS synthase 2 and DHEA sulfotransferase SULT2A1.
Mueller JW; Idkowiak J; Gesteira TF; Vallet C; Hardman R; van den Boom J; Dhir V; Knauer SK; Rosta E; Arlt W
J Biol Chem; 2018 Jun; 293(25):9724-9735. PubMed ID: 29743239
[TBL] [Abstract][Full Text] [Related]
7. Tissue distribution and ontogeny of sulfotransferase enzymes in mice.
Alnouti Y; Klaassen CD
Toxicol Sci; 2006 Oct; 93(2):242-55. PubMed ID: 16807285
[TBL] [Abstract][Full Text] [Related]
8. Estrogen sulfotransferase in the metabolism of estrogenic drugs and in the pathogenesis of diseases.
Barbosa ACS; Feng Y; Yu C; Huang M; Xie W
Expert Opin Drug Metab Toxicol; 2019 Apr; 15(4):329-339. PubMed ID: 30822161
[TBL] [Abstract][Full Text] [Related]
9. Human 3'-phosphoadenosine 5'-phosphosulfate synthetase 1 (PAPSS1) and PAPSS2: gene cloning, characterization and chromosomal localization.
Xu ZH; Otterness DM; Freimuth RR; Carlini EJ; Wood TC; Mitchell S; Moon E; Kim UJ; Xu JP; Siciliano MJ; Weinshilboum RM
Biochem Biophys Res Commun; 2000 Feb; 268(2):437-44. PubMed ID: 10679223
[TBL] [Abstract][Full Text] [Related]
10. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
11. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
[TBL] [Abstract][Full Text] [Related]
12. Increased SULT1E1 activity in HepG2 hepatocytes decreases growth hormone stimulation of STAT5b phosphorylation.
Li L; He D; Wilborn TW; Falany JL; Falany CN
Steroids; 2009 Jan; 74(1):20-9. PubMed ID: 18831980
[TBL] [Abstract][Full Text] [Related]
13. Estrogen dependency in uterine endometrial cancers.
Fujimoto J; Hirose R; Sakaguchi H; Tamaya T
Oncology; 1998 Dec; 55 Suppl 1():53-9. PubMed ID: 9852402
[TBL] [Abstract][Full Text] [Related]
14. The sulfatase pathway as estrogen supply in endometrial cancer.
Cornel KMC; Delvoux B; Saya T; Xanthoulea S; Konings GFJ; Kruitwagen RPFM; Bongers MY; Kooreman L; Romano A
Steroids; 2018 Nov; 139():45-52. PubMed ID: 30217785
[TBL] [Abstract][Full Text] [Related]
15. Annonacin induces cell cycle-dependent growth arrest and apoptosis in estrogen receptor-α-related pathways in MCF-7 cells.
Ko YM; Wu TY; Wu YC; Chang FR; Guh JY; Chuang LY
J Ethnopharmacol; 2011 Oct; 137(3):1283-90. PubMed ID: 21840388
[TBL] [Abstract][Full Text] [Related]
16. Garcinol, an acetyltransferase inhibitor, suppresses proliferation of breast cancer cell line MCF-7 promoted by 17β-estradiol.
Ye X; Yuan L; Zhang L; Zhao J; Zhang CM; Deng HY
Asian Pac J Cancer Prev; 2014; 15(12):5001-7. PubMed ID: 24998578
[TBL] [Abstract][Full Text] [Related]
17. Regulation of estrogen activity by sulfation in human MCF-7 breast cancer cells.
Falany JL; Falany CN
Oncol Res; 1997; 9(11-12):589-96. PubMed ID: 9563006
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and cancers: the biological roles of estrogen and progestin in tumorigenesis are different between the endometrium and breast.
Ito K
Tohoku J Exp Med; 2007 May; 212(1):1-12. PubMed ID: 17464097
[TBL] [Abstract][Full Text] [Related]
19. Estrogen sulfotransferases in breast and endometrial cancers.
Pasqualini JR
Ann N Y Acad Sci; 2009 Feb; 1155():88-98. PubMed ID: 19250196
[TBL] [Abstract][Full Text] [Related]
20. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
Hellsten R; Johansson M; Dahlman A; Dizeyi N; Sterner O; Bjartell A
Prostate; 2008 Feb; 68(3):269-80. PubMed ID: 18163422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
